Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model

Andreas Zeitvogel, A Zeitvogel, R Baumann, Rudolf Baumann, Anna Starzinski‐Powitz, A Starzinski-Powitz
The American journal of pathology · 2001 · vol. 159(5) , pp. 1839–1852 · doi:10.1016/s0002-9440(10)63030-1 · PMID:11696444 · W1975047209
article OA: green CC0 ⤵ 197 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Researchers identified a novel N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Cadherins Cytological Techniques Endometriosis Endometriosis Biocompatible Materials Cadherins Cell Division Cell Movement Cell Movement Cells, Cultured Collagen Drug Combinations Endometriosis Epithelial Cells Epithelial Cells Epithelial Cells Female Humans Laminin Peritoneum

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:19.284922+00:00
License: CC0 · commercial use OK